BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21246754)

  • 1. Transformation of rat intestinal epithelial cells by overexpression of Rab25 is microtubule dependent.
    Lapierre LA; Caldwell CM; Higginbotham JN; Avant KM; Hall J; Beauchamp RD; Goldenring JR
    Cytoskeleton (Hoboken); 2011 Feb; 68(2):97-111. PubMed ID: 21246754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas.
    Nam KT; Lee HJ; Smith JJ; Lapierre LA; Kamath VP; Chen X; Aronow BJ; Yeatman TJ; Bhartur SG; Calhoun BC; Condie B; Manley NR; Beauchamp RD; Coffey RJ; Goldenring JR
    J Clin Invest; 2010 Mar; 120(3):840-9. PubMed ID: 20197623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rab25 regulates integrin expression in polarized colonic epithelial cells.
    Krishnan M; Lapierre LA; Knowles BC; Goldenring JR
    Mol Biol Cell; 2013 Mar; 24(6):818-31. PubMed ID: 23345591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of RAB25 Cooperates with Oncogenes in the Transformation of Human Mammary Epithelial Cells (HMECs) to Give Rise to Claudin-Low Tumors.
    Joshi P; Ayyagari V; Kandel S; Modur V; Iqbal MF; Robinson K; Gao J; Rao K
    Biomed Res Int; 2024; 2024():8544837. PubMed ID: 38803515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells.
    Allen CE; Du J; Jiang B; Huang Q; Yakovich AJ; Barnard JA
    Neoplasia; 2008 Oct; 10(10):1073-82. PubMed ID: 18813357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo.
    Fan Y; Xin XY; Chen BL; Ma X
    Pathology; 2006 Dec; 38(6):561-7. PubMed ID: 17393986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K; Sheng H; Shao J; Beauchamp RD
    Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.
    Shields JM; Mehta H; Pruitt K; Der CJ
    Mol Cell Biol; 2002 Apr; 22(7):2304-17. PubMed ID: 11884615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells.
    Sheng GG; Shao J; Sheng H; Hooton EB; Isakson PC; Morrow JD; Coffey RJ; DuBois RN; Beauchamp RD
    Gastroenterology; 1997 Dec; 113(6):1883-91. PubMed ID: 9394727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRTF-A/B suppress the oncogenic properties of v-ras- and v-src-mediated transformants.
    Yoshio T; Morita T; Tsujii M; Hayashi N; Sobue K
    Carcinogenesis; 2010 Jul; 31(7):1185-93. PubMed ID: 20338973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation.
    Kim MJ; Woo SJ; Yoon CH; Lee JS; An S; Choi YH; Hwang SG; Yoon G; Lee SJ
    J Biol Chem; 2011 Apr; 286(15):12924-32. PubMed ID: 21300795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells.
    Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rab25 as a tumour suppressor in colon carcinogenesis.
    Goldenring JR; Nam KT
    Br J Cancer; 2011 Jan; 104(1):33-6. PubMed ID: 21063400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
    Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
    J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer.
    Gomez-Roman N; Sahasrabudhe NM; McGregor F; Chalmers AJ; Cassidy J; Plumb J
    Oncotarget; 2016 Apr; 7(16):22650-64. PubMed ID: 26967059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Rab25 promotes the development of skin squamous cell carcinoma through the dysregulation of integrin trafficking.
    Jeong H; Lim KM; Kim KH; Cho Y; Lee B; Knowles BC; Roland JT; Zwerner JP; Goldenring JR; Nam KT
    J Pathol; 2019 Oct; 249(2):227-240. PubMed ID: 31144312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts.
    Rak J; Mitsuhashi Y; Sheehan C; Tamir A; Viloria-Petit A; Filmus J; Mansour SJ; Ahn NG; Kerbel RS
    Cancer Res; 2000 Jan; 60(2):490-8. PubMed ID: 10667605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β-catenin pathway in NSCLC.
    Wang J; Zhou P; Wang X; Yu Y; Zhu G; Zheng L; Xu Z; Li F; You Q; Yang Q; Zhuo W; Sun J; Chen Z
    Cell Prolif; 2019 May; 52(3):e12592. PubMed ID: 30848009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenomatous polyposis coli mutants dominantly activate Hsf1-dependent cell stress pathways through inhibition of microtubule dynamics.
    Davies AE; Kortright K; Kaplan KB
    Oncotarget; 2015 Sep; 6(28):25202-16. PubMed ID: 26320184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.